NCT02679456View on ClinicalTrials.gov

Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 5, 2016

Study Completion Date

August 5, 2016

Conditions

Vulvovaginal Candidiasis

Interventions

DRUG

SCY-078

DRUG

Fluconazole

Trial Locations (2)

Unknown

Hospital Dr. Francisco E. Moscoso Puello, Santo Domingo

Instituto Dermatologico y Cirugia de Piel, Santo Domingo

All Listed Sponsors

collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

Scynexis, Inc.

INDUSTRY

NCT02679456 - Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis | Biotech Hunter | Biotech Hunter